Salvat
ApprovedSalvat’s goal is to be a hub in the development of pharmaceutical technologies with a primary focus on Otolaryngology and Ophthalmology. We have a strong calling for innovation.
Founded
1955
Employees
201-500
Focus
Small Molecules
About
Salvat’s goal is to be a hub in the development of pharmaceutical technologies with a primary focus on Otolaryngology and Ophthalmology. We have a strong calling for innovation.
Funding History
1Total raised: $12M
Series A$12MYsios CapitalSep 15, 2021
Company Info
TypePrivate
Founded1955
Employees201-500
LocationBarcelona, Spain
StageApproved
Contact
Sectors
SIMILAR COMPANIES
A4Cell
Pre-clinical · Barcelona
Ability Pharma
Phase 2 · Barcelona
Abyntek Biopharma
Pre-clinical · Derio
Acellera
Pre-clinical · Barcelona
BeCytes Biotechnologies
Pre-clinical · Barcelona
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile